US3580291066
US3580291066
Fresenius Medical Care AG
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 11.21B EUR | 12.14B EUR | 6.09B EUR | 6.65B EUR |
Enterprise Value | 22B EUR | 12.14B EUR | 15.88B EUR | 15.87B EUR |
Valuation Multiples | ||||
Trailing P/E | 10.86x | 16.87x | 6.45x | 6.8x |
Forward P/E | 7.04x | -- | -- | -- |
Price to Sales | 0.58x | 0.83x | 0.31x | 0.34x |
Price to Book | 0.79x | -- | 0.46x | 0.5x |
EV/Revenue | 1.13x | 0.83x | 0.82x | 0.81x |
EV/EBITDA | 8.09x | 4.34x | 4.39x | 4.45x |
Price to FCF (P/FCF) | 5.54x | 10.42x | 3.41x | 3.77x |
EV/FCF | 10.88x | 10.42x | 8.9x | 8.99x |
FCF Yield | 18.04% | 9.6% | 29.3% | 26.54% |